Login / Signup

Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry.

Ahmet KarataşRabia Pişkin SağırSuleyman Serdar KocaHüseyin Ediz DalkılıçGercek SenPehlivan YavuzAyten YazıcıGüzide Nevsun İnançAyşe CefleZeynep ErtürkServet AkarAbdurrahman Soner ŞenelAhmet Merih BirlikNurullah AkkocFatoş Önen
Published in: Turkish journal of medical sciences (2023)
In obese and nonobese patients with RA, rituximab treatment exhibits similar side effects and similar long-term efficacy. These results suggest that obesity does not alter drug survival for rituximab and response rates, in RA and rituximab may be a favorable treatment agent in patients with RA and obesity.
Keyphrases